CAXTON CORP 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:57 pm Sale |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
CAXTON CORP | 1,119,322 7.000% |
-23,039 (-2.02%) |
Filing |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Sierra Oncology, Inc. SRRA |
CAXTON CORP | 1,142,361 9.900% |
60,161 (+5.56%) |
Filing |